Durability of COVID-19 humoral immunity post infection and different SARS-COV-2 vaccines
Background: The global challenge posed by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has been a major concern for the healthcare sector in recent years. Healthcare workers have a relatively high risk of encountering COVID-19 patients, making protective immunity against SARS-CoV-2 i...
Saved in:
Main Authors: | Fayhan Alroqi (Author), Tlili Barhoumi (Author), Emad Masuadi (Author), Maysa Nogoud (Author), Modhi Aljedaie (Author), Ahmad Selah Abu-Jaffal (Author), Maha Bokhamseen (Author), Myaad Saud (Author), Maumonah Hakami (Author), Yaseen M. Arabi (Author), Amre Nasr (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area
by: Fayhan Alroqi, et al.
Published: (2021) -
Humoral immunity for durable control of SARS-CoV-2 and its variants
by: Ryutaro Kotaki, et al.
Published: (2023) -
The Role of Interleukin-1 cytokine family (IL-1β, IL-37) and interleukin-12 cytokine family (IL-12, IL-35) in eumycetoma infection pathogenesis.
by: Amir Abushouk, et al.
Published: (2019) -
Successful treatment of invasive mycobacterium infection with interferon beta in a patient with Interferon-Gamma Receptor 1 deficiency
by: Fayhan Alroqi, et al.
Published: (2024) -
Immunization with Pneumocystis recombinant KEX1 induces robust and durable humoral responses in immunocompromised non-human primates
by: Viviana Cobos Jiménez, et al.
Published: (2019)